Cranford Pharmaceuticals (Inderal XL)

Cranford Pharmaceuticals (Inderal XL) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Cranford Pharmaceuticals (Inderal XL) General Information

Description

A beta adrenergic blocker and capsule intended for the treatment of hypertension, to lower blood pressure.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 11 Commerce Drive Floor 1
  • Cranford, NJ 07016
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cranford Pharmaceuticals (Inderal XL) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cranford Pharmaceuticals (Inderal XL)‘s full profile, request access.

Request a free trial

Cranford Pharmaceuticals (Inderal XL) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cranford Pharmaceuticals (Inderal XL)‘s full profile, request access.

Request a free trial